Yimei Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yimei Jin has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Chia-Chi Chang
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
18 shared publications - Christine B. Peterson
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA
18 shared publications - Eiko Hayase
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
18 shared publications - Jeffrey J. Molldrem
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
18 shared publications - Rishika Prasad
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
18 shared publications - Robert R. Jenq
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA
18 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Generation of reporter cells overexpressing CaSki cDNA library.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Generation of reporter cells overexpressing CaSki cDNA library.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Activation of Fas-iNFκB reporter in FIR-APCs.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Activation of Fas-iNFκB reporter in FIR-APCs.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Tsyn-seq system spike-in assay.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Tsyn-seq system spike-in assay.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Aggregates of interacting target cells and T cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Aggregates of interacting target cells and T cells.
- Open Access
- 13 March 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (6) , 1979-1991
Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD
Lower gastrointestinal graft-versus-host disease (LGI-GVHD) carries morbidity and mortality for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), with critical contributions from the intestinal microbiome. In a retrospective cohort of metagenomic sequencing of stool from patients with allo-HSCT (N = 90), we found that a reduction in specific Parabacteroides and Bacteroides species around the time of engraftment contributes to LGI-GVHD risk. Given the known diverse carbohydrate-degrading functionality of these bacteria, we investigated gene abundances for carbohydrate-active enzymes (CAZymes) and found that Parabacteroides merdae, P distasonis, and Bacteroides ovatus abundances were significantly correlated with CAZymes in patients who did not develop LGI-GVHD compared with those who did. The specific gene abundances of xylosidase, which contribute to the degradation of xylose-containing polysaccharides, were significantly associated with a reduced risk of LGI-GVHD. All these findings show the importance of the carbohydrate-degrading functionality of putative beneficial bacteria in mediating risk of LGI-GVHD.
- 13 March 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (6) , 1979-1991
Open AccessFecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD
Lower gastrointestinal graft-versus-host disease (LGI-GVHD) carries morbidity and mortality for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), with critical contributions from the intestinal microbiome. In a retrospective cohort of metagenomic sequencing of stool from patients with allo-HSCT (N = 90), we found that a reduction in specific Parabacteroides and Bacteroides species around the time of engraftment contributes to LGI-GVHD risk. Given the known diverse carbohydrate-degrading functionality of these bacteria, we investigated gene abundances for carbohydrate-active enzymes (CAZymes) and found that Parabacteroides merdae, P distasonis, and Bacteroides ovatus abundances were significantly correlated with CAZymes in patients who did not develop LGI-GVHD compared with those who did. The specific gene abundances of xylosidase, which contribute to the degradation of xylose-containing polysaccharides, were significantly associated with a reduced risk of LGI-GVHD. All these findings show the importance of the carbohydrate-degrading functionality of putative beneficial bacteria in mediating risk of LGI-GVHD.
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S2 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Aggregates of interacting target cells and T cells.
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Aggregates of interacting target cells and T cells.
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S1 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Activation of Fas-iNFκB reporter in FIR-APCs.
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Activation of Fas-iNFκB reporter in FIR-APCs.
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
- Open Access
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S4 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Generation of reporter cells overexpressing CaSki cDNA library.
- 2 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform
Generation of reporter cells overexpressing CaSki cDNA library.